| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,149 |
6,355 |
$181K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,839 |
4,595 |
$140K |
| 99444 |
|
2,209 |
580 |
$126K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,867 |
1,953 |
$18K |
| 99441 |
|
1,086 |
916 |
$14K |
| 86769 |
|
450 |
185 |
$12K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,884 |
3,236 |
$10K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
914 |
414 |
$8K |
| 99000 |
|
989 |
844 |
$6K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
354 |
293 |
$6K |
| 99423 |
|
508 |
38 |
$5K |
| 71047 |
|
205 |
181 |
$4K |
| 93000 |
|
579 |
518 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,297 |
1,164 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
907 |
782 |
$3K |
| 82948 |
|
4,258 |
3,260 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
73 |
61 |
$3K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
46 |
37 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
242 |
209 |
$2K |
| 99490 |
Ccm add 20min |
960 |
959 |
$2K |
| 81003 |
|
2,944 |
2,526 |
$2K |
| 99422 |
|
92 |
41 |
$2K |
| 87650 |
|
213 |
187 |
$2K |
| 99421 |
|
81 |
33 |
$1K |
| 99051 |
|
1,518 |
1,210 |
$1K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
19 |
14 |
$989.72 |
| 99050 |
|
90 |
80 |
$867.66 |
| 85027 |
|
269 |
242 |
$836.22 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
55 |
44 |
$813.66 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
18 |
14 |
$709.24 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
598 |
420 |
$630.15 |
| 71046 |
Radiologic examination, chest; 2 views |
148 |
133 |
$456.22 |
| 99442 |
|
17 |
15 |
$427.89 |
| 74018 |
|
18 |
16 |
$360.59 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
389 |
322 |
$302.34 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
629 |
489 |
$247.10 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
128 |
121 |
$233.00 |
| 92552 |
|
34 |
21 |
$227.34 |
| 81002 |
|
195 |
181 |
$170.25 |
| 92250 |
|
14 |
14 |
$155.40 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
391 |
307 |
$139.11 |
| 90756 |
|
147 |
140 |
$93.91 |
| 93923 |
|
30 |
30 |
$42.94 |
| 36415 |
Collection of venous blood by venipuncture |
5,558 |
4,644 |
$18.90 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
688 |
617 |
$14.55 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
58 |
24 |
$13.20 |
| 99173 |
|
61 |
40 |
$3.60 |
| 1000F |
|
929 |
771 |
$0.00 |
| 1126F |
|
7,581 |
6,125 |
$0.00 |
| 3074F |
|
7,257 |
5,646 |
$0.00 |
| 4086F |
|
623 |
522 |
$0.00 |
| 1036F |
|
10,993 |
8,408 |
$0.00 |
| 1125F |
|
2,746 |
2,337 |
$0.00 |
| 2000F |
|
7,914 |
6,234 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
8,818 |
6,911 |
$0.00 |
| 3044F |
|
255 |
213 |
$0.00 |
| 2010F |
|
9,977 |
7,351 |
$0.00 |
| 1101F |
|
606 |
553 |
$0.00 |
| 3079F |
|
2,247 |
1,881 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
3,227 |
2,672 |
$0.00 |
| 99070 |
|
556 |
377 |
$0.00 |
| 3008F |
|
8,911 |
6,789 |
$0.00 |
| 2001F |
|
8,975 |
6,822 |
$0.00 |
| G9664 |
Patients who are currently statin therapy users or received an order (prescription) for statin therapy |
1,790 |
1,496 |
$0.00 |
| 3075F |
|
268 |
241 |
$0.00 |
| 36416 |
|
205 |
154 |
$0.00 |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
451 |
387 |
$0.00 |
| 1170F |
|
111 |
94 |
$0.00 |
| 82962 |
|
81 |
65 |
$0.00 |
| 4050F |
|
155 |
134 |
$0.00 |
| 1220F |
|
13 |
12 |
$0.00 |
| 1111F |
|
54 |
50 |
$0.00 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
118 |
104 |
$0.00 |
| 4010F |
|
20 |
19 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
18 |
16 |
$0.00 |
| G8755 |
Most recent diastolic blood pressure >= 90 mmhg |
12 |
12 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
17 |
12 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
6,788 |
5,429 |
$0.00 |
| 1159F |
|
4,842 |
3,926 |
$0.00 |
| 99401 |
|
487 |
311 |
$0.00 |
| G0247 |
Routine foot care by a physician of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include, the local care of superficial wounds (i.e. superficial to muscle and fascia) and at least the following if present: (1) local care of superficial wounds, (2) debridement of corns and calluses, and (3) trimming and debridement of nails |
399 |
325 |
$0.00 |
| 1026F |
|
161 |
141 |
$0.00 |
| 2014F |
|
929 |
772 |
$0.00 |
| 3288F |
|
1,347 |
1,162 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
7,635 |
6,004 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
932 |
810 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
1,898 |
1,581 |
$0.00 |
| 1160F |
|
1,370 |
1,097 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
8,462 |
6,684 |
$0.00 |
| 1003F |
|
6,780 |
5,226 |
$0.00 |
| G8935 |
Clinician prescribed angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy |
239 |
222 |
$0.00 |
| 3078F |
|
5,541 |
4,265 |
$0.00 |
| G0246 |
Follow-up physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include at least the following: (1) a patient history, (2) a physical examination that includes: (a) visual inspection of the forefoot, hindfoot and toe web spaces, (b) evaluation of protective sensation, (c) evaluation of foot structure and biomechanics, (d) evaluation of vascular status and skin integrity, and (e) evaluation and recommendation of footwear, and (3) patient education |
233 |
193 |
$0.00 |
| 0518F |
|
740 |
663 |
$0.00 |
| 0521F |
|
2,330 |
1,992 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
270 |
248 |
$0.00 |
| 3725F |
|
65 |
60 |
$0.00 |
| 3077F |
|
219 |
197 |
$0.00 |
| 4158F |
|
15 |
15 |
$0.00 |
| G9781 |
Documentation of medical reason(s) for not currently being a statin therapy user or receiving an order (prescription) for statin therapy (e.g., patients with statin-associated muscle symptoms or an allergy to statin medication therapy, patients who are receiving palliative or hospice care, patients with active liver disease or hepatic disease or insufficiency, patients with end stage renal disease [esrd], or other medical reasons) |
378 |
319 |
$0.00 |
| 1033F |
|
2,097 |
1,778 |
$0.00 |
| 3006F |
|
52 |
50 |
$0.00 |
| G8598 |
Aspirin or another antiplatelet therapy used |
645 |
563 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
221 |
213 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
59 |
56 |
$0.00 |
| 2028F |
|
52 |
43 |
$0.00 |
| 4013F |
|
138 |
123 |
$0.00 |
| 4004F |
|
22 |
21 |
$0.00 |
| 3210F |
|
413 |
340 |
$0.00 |
| 99499 |
|
50 |
27 |
$0.00 |
| 4040F |
|
31 |
30 |
$0.00 |
| 99071 |
|
15 |
15 |
$0.00 |
| 2022F |
|
13 |
13 |
$0.00 |
| G8451 |
Beta-blocker therapy for lvef <=40% not prescribed for reasons documented by the clinician (e.g., low blood pressure, fluid overload, asthma, patients recently treated with an intravenous positive inotropic agent, allergy, intolerance, other medical reasons, patient declined, other patient reasons) |
37 |
35 |
$0.00 |